Rheumatoid Arthritis Clinical Trials in Sacramento, CA

About Rheumatoid Arthritis Clinical Trials in Sacramento

Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.

There are currently 35 rheumatoid arthritis clinical trials recruiting participants in Sacramento, CA. These studies are seeking a combined 12,585 participants. Research is being sponsored by Genzyme, a Sanofi Company, Alliance for Clinical Trials in Oncology, Vertex Pharmaceuticals Incorporated and 23 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.